Danaher Corporation $DHR Shares Bought by Baird Financial Group Inc.

Key Points

• Baird Financial Group Inc. significantly increased its stake in Danaher Corporation by 290.6% in the first quarter, bringing its total ownership to about 1.44 million shares valued at approximately $295.55 million.
• Wall Street analysts have shown a positive outlook on Danaher, with 17 analysts rating it as a Buy and a consensus target price of $247.61.
• Danaher reported a revenue of $5.94 billion for the last quarter, exceeding analyst estimates, alongside an EPS of $1.80, outpacing the expected $1.64.

Baird Financial Group Inc. lifted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 290.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,441,706 shares of the conglomerate's stock after purchasing an additional 1,072,617 shares during the period. Baird Financial Group Inc. owned about 0.20% of Danaher worth $295,550,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of DHR. Heck Capital Advisors LLC purchased a new stake in Danaher during the fourth quarter worth $27,000. GHP Investment Advisors Inc. raised its position in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after acquiring an additional 99 shares in the last quarter. Sierra Ocean LLC boosted its holdings in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after buying an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in shares of Danaher in the 1st quarter worth approximately $31,000. Finally, Dunhill Financial LLC raised its stake in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after acquiring an additional 67 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the company's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 11.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. Wells Fargo & Company cut their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 23rd. Barclays restated an "overweight" rating and set a $225.00 target price (up from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Evercore ISI decreased their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Guggenheim reissued a "buy" rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Finally, Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and a consensus target price of $247.61.

Danaher Stock Performance

DHR traded down $2.02 during trading on Tuesday, reaching $203.80. 2,388,966 shares of the company's stock were exchanged, compared to its average volume of 4,161,300. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90. The company's fifty day simple moving average is $201.84 and its 200-day simple moving average is $199.46. The stock has a market capitalization of $145.93 billion, a P/E ratio of 43.36, a price-to-earnings-growth ratio of 2.87 and a beta of 0.75.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business's quarterly revenue was up 3.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.